**RE-SCHEDULED**
Re-imagining Medicine: The New Paradigm Shift in Treating Low Back Pain
Only Laser FDA Cleared for Chronic Low Back Pain
Tuesday, August 11th, 2020 | 2:00pm-3:00pm EST
with Erchonia’s
President – Steve Shanks
Clinical Affairs Manager – Travis Sammons



 Quality Not Compromise 

Erchonia made history in 2018 when the FDA gave Erchonia market clearance as the First non-invasive device for Chronic Low Back Pain. This webinar will walk you through the FDA research process, clinical results, and the continued dedication to research. We will also review the proven mechanisms and biomarkers that contribute to the reduction of pain and inflammation.

Key Take-Aways:

  • Low Back Pain Market
  • Clinical research process
  • FDA research results from Double Blind, Placebo Controlled Trial
  • New Published Long term follow-up data
  • Photochemical vs. Photothermal

Register

View Full Research Article
Follow us!

FacebookLinkLinkedIn